Tamsulosin Hydrochloride Capsule
Product Images NDC 62756-160

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 62756-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Tamsulosin Fig1)

A pharmacokinetic line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time in hours up to 36 hours. Two curves compare concentrations under fasted and fed conditions, with the fasted state showing a higher peak concentration earlier than the fed state.*

FDA Label Image

Figure-2a (Tamsulosin Fig2a)

A line graph showing mean change over a 13-week treatment duration, comparing Tamsulosin Hydrochloride doses of 0.4 mg and 0.8 mg versus placebo. The x-axis represents weeks of treatment, with sample sizes indicated, and the y-axis shows mean change values from baseline. The treatment groups demonstrate decreasing mean change over time, with the 0.8 mg dose showing the greatest change, and placebo the least.*

FDA Label Image

Figure-2b (Tamsulosin Fig2b)

A line graph showing mean change over duration of treatment in weeks comparing three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and Placebo. The x-axis represents treatment duration from 0 to 13 weeks plus LOCF, and the y-axis represents mean change from 0 to -11. Data points are marked with circles for 0.8 mg, triangles for 0.4 mg, and squares for placebo, illustrating a decreasing trend in mean change for both Tamsulosin doses compared to placebo over time.*

FDA Label Image

Tamsulosin-fig3a (Tamsulosin Fig3a)

A line graph showing mean change in mL/sec over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change (mL/sec) from 0 to 3, and the x-axis shows treatment duration from baseline to 13 weeks and LOCF. The 0.8 mg and 0.4 mg groups show higher mean change compared to placebo over time.*

FDA Label Image

Tamsulosin-fig3b (Tamsulosin Fig3b)

A line chart showing mean change in mL/sec over treatment duration in weeks for Tamsulosin Hydrochloride at 0.4 mg and 0.8 mg doses compared to placebo. The chart includes data points at weeks 0, 1, 2, 5, 9, 13, and LOCF, demonstrating treatment effects over time with three distinct lines for each group.*

FDA Label Image

Tamsulosin-label (Tamsulosin Label)

Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg by Sun Pharmaceutical Industries, Inc. The label indicates 90 capsules per container, prescription-only, with storage instructions and warnings. It includes the NDC 62756-160-81 and distribution and manufacturing information for Sun Pharma in New Jersey, USA, and Gujarat, India.*

FDA Label Image

Chemical-structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride showing its molecular arrangement with functional groups and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.